跳至主要内容
临床试验/NCT03901521
NCT03901521Enrolling By Invitation不适用

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Weill Medical College of Cornell University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
100
试验地点
1
主要终点
The presence of somatic PKD 1/2 gene mutations in cyst epithelial cells

研究概览

简要总结

This study will analyze the germline and somatic mutations underlying the development of ADPKD in order to better understand the genetic mechanism responsible for the cystic transformation. Once identified, these mutations could help us understand better the mechanism leading to the development of this disease and may explain at least in part the phenotypic variability.

详细描述

The presentation of ADPKD renal and extrarenal manifestations varies widely, even within families, and has been attributed to numerous genetic factors. One principal explanation came with the discovery that renal cyst lining cells from ADPKD patients undergo secondary somatic mutations, selective loss of the second copy of a respective normal polycystic kidney disease (PKD) gene. These somatic mutations can occur in either polycystic kidney disease 1 (PKD1) or polycystic kidney disease 2 (PKD2). Furthermore, various cysts in the same patient have been reported to harbor different somatic mutations. These findings implicated a cellular recessive mechanism for cyst formation in ADPKD, suggesting the possibility that the observed intra-familial variation in disease phenotype may, at least in part, be explained by variation in mutation type, the timing and number of somatic "second-hit" mutations in individual family members affected with the disease. However, there is currently very little known about the cellular genetic mechanism leading to cysts development and very few studies, addressing this issue.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females
  • 18 years of age or older
  • Confirmed diagnosis of ADPKD
  • Undergoing a native nephrectomy
  • Willing and able to provide informed consent

排除标准

  • Unable or unwilling to provide informed consent

结局指标

主要结局

The presence of somatic PKD 1/2 gene mutations in cyst epithelial cells

时间窗: 10 YEARS

The presence of mutations will be measured by next generation sequencing (NGS) and other tools for mutation analysis.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Autosomal Dominant Polycystic Kidney Disease Somatic... | 临床试验